Wood LJ, Mukherjee M, Tesfaye
A, Sumter Felder T, and Resar LMS. (2007) HMGA2 is required for transformation in human
lung cancer. (In preparation).
Felder
Sumter T, Dhara S, Bhattacharya R, Turkson J, Jove R, and Resar LMS. (2007) STAT3:
An HMGA1a target gene
up-regulated in leukemogenesis
and a possible therapeutic target. (Submitted)
Gray
T, Morrey EL, Gangadharan B, Sumter T.F.,
Spychala J, Archer DR, Spencer HT. (2006) “Enforced
expression of cytosolic 5'-nucleotidase I confers
resistance to nucleoside analogues in vitro but systemic chemotherapy toxicity
precludes in vivo selection,” Cancer Chemother
Pharmacol. 2006
Jul; 58(1):117-28
Sumter, T.
(2005) “Navigating the First Year of
Felder, T. (2004)
“Nothing is Impossible to a Willing Heart: Experiences of Minorities in
Science” Science’s Nextwave.
5, doi
Hommura,
F., Katabumi,
M., Leaner, V.D., Donninger, H., Sumter T.F., Resar, L.M., Birrer, M.J.
(2004) HMG-I/Y is a c-Jun/activator protein-1 target gene and is necessary for
c-Jun-induced anchorage-independent growth in Rat1a cells. Mol. Cancer Res. 2:305-314.
Xu, Y., Felder-Sumter,
T. , Bhattacharya, R., Tesfaye, A., Fuchs, E.J.,
Wood L.J., Huso, D., Resar, L.M.S. (2004) The HMG-I
Oncogene causes highly penetrant, aggressive lymphoid
malignancy in transgenic mice and is overexpressed in human leukemia. Cancer Res. 64:3371-3375.
M.C. Nivens, T. Felder,
A. Galloway*, M. Pena, J. Pouliot, and H.T. Spencer. (2003) "Engineered resistance
to camptothecin and antifolates
by retroviral co-expression of tyrosyl DNA
Phosphodiesterase-1 and thymidylate synthase” Cancer
Chemotherapy and Pharmacology. e-published
ahead of print
T. Felder, R.
B. Dunlap, D. Dix, and T. Spencer. (2002) “Differences in
natural ligand and fluoropyrimidine
binding to human thymidylate synthase
identified by transient-state spectroscopic and continuous variation methods.
Biochim Biophys
Acta. 1597:149-56.
Stephens,
C.E., Felder, T.M., Sowell, J.W., Adrei, G., Balz, J., Snoeck, R., De Clerq, E. (2001)
“Synthesis and Antiviral Evaluation of 2-Amino- and
2-Carboxamido-3-arylsulfonylthiophenes and Related Compounds as a New Class of Diarylsulfones.
Bioorg. Med. Chem.
9: 1123-1132.